Syndax Pharmaceuticals IncSNDX
| Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Cash and cash equivalents | 24 | 35 | 34 | 25 | 115 | 222 | 74 |
---|
Restricted cash | - | - | - | 0 | 0 | 0 | - |
---|
Short-term investments | 81 | 95 | 47 | 35 | 178 | 218 | 401 |
---|
Short-term deposits | - | - | - | - | 5 | 7 | 9 |
---|
Collaboration receivable | - | - | - | - | - | - | 3 |
---|
Prepaid expenses and other current assets | 3 | 3 | 2 | 3 | 6 | 8 | 2 |
---|
Total current assets | 109 | 133 | 83 | 62 | 299 | 448 | 490 |
---|
Long-Term Investments | - | 3 | - | - | - | - | 5 |
---|
Property and equipment, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Right-of-use asset | - | - | - | 1 | 0 | 1 | 1 |
---|
Restricted cash | - | - | - | - | - | - | 0 |
---|
Other assets | 0 | 0 | 0 | 0 | 1 | - | 1 |
---|
Total assets | 109 | 137 | 84 | 64 | 301 | 450 | 497 |
---|
Accounts payable | 2 | 2 | 1 | 6 | 4 | 6 | 4 |
---|
Accrued Liabilities and Other Liabilities | 7 | 12 | 13 | 10 | 11 | 14 | 24 |
---|
Operating Lease, Liability, Current | - | - | - | 0 | 0 | 0 | 0 |
---|
Current Portion Of Capital Lease | - | - | - | - | - | - | 0 |
---|
Derivative liability | - | - | - | - | - | 0 | - |
---|
Total current liabilities | 10 | 16 | 16 | 18 | 19 | 21 | 29 |
---|
Operating Lease, Liability, Noncurrent | - | - | - | 0 | 0 | 1 | 1 |
---|
Capital Lease Less Current Portion | - | - | - | - | - | - | 0 |
---|
Loans Payable, Noncurrent | - | - | - | - | 18 | 20 | - |
---|
Total long-term liabilities | 15 | 17 | 15 | 14 | 30 | 21 | 1 |
---|
Total liabilities | 25 | 33 | 31 | 32 | 48 | 41 | 30 |
---|
Preferred Stock, Value, Issued | - | - | - | - | - | - | - |
---|
Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid-in capital | 389 | 471 | 492 | 527 | 821 | 952 | 1,161 |
---|
Accumulated other comprehensive (loss) income | 0 | -0 | -0 | - | -0 | 0 | -1 |
---|
Accumulated deficit | -305 | -366 | -439 | -495 | -569 | -544 | -693 |
---|
Total stockholders' equity | 84 | 104 | 53 | 32 | 252 | 408 | 467 |
---|
Total liabilities and stockholders' equity | 109 | 137 | 84 | 64 | 301 | 450 | 497 |
---|